A Prospective Observational Registry to describe the disease course and outcomes of Idiopathic Pulmonary Fibrosis patients in a real-world clinical setting (PROOF-R)

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/11789
• EU PAS number:
  EUPAS11788
• Study ID:
  11789
• Official title and acronym:
  A Prospective Observational Registry to describe the disease course and outcomes of Idiopathic Pulmonary Fibrosis patients in a real-world clinical setting (PROOF-R)
• DARWIN EU® study:
  No
• Study countries:
  Belgium

  Luxembourg
• Study status:
  Ongoing

Study timelines

Date when funding contract was signed

Actual: 09/04/2013

Study start date

Actual: 22/10/2013

Date of final study report

Planned: 03/06/2019

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Roche

Regulatory

• Was the study required by a regulatory body?:
  Yes